Collaboration between pharmacy and laboratory: Defining total allowable error limits for therapeutically monitored drugs

Annals of Pharmacotherapy

Volumn 32, Issue 2, 1998, Pages 170-175

  Radomski, Kristine M ^a,b,c   Bush, Barbara A ^d   Ensom, Mary H H ^a,d,e,f  

^a University of Kentucky   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

Drug assays; Therapeutic monitoring

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIGOXIN; GENTAMICIN; LIDOCAINE; PHENOBARBITAL; PRIMIDONE; PROCAINAMIDE; QUINIDINE; THEOPHYLLINE; TOBRAMYCIN; VALPROIC ACID; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ANTICONVULSANT THERAPY; ARTICLE; CONGESTIVE HEART FAILURE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; LABORATORY TEST; MALE; PRIORITY JOURNAL;

ADULT; BLOOD CHEMICAL ANALYSIS; DRUG MONITORING; HUMANS; LABORATORIES, HOSPITAL; MATHEMATICAL COMPUTING; PHARMACY SERVICE, HOSPITAL; QUALITY CONTROL;

EID: 0031952768     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.17187     Document Type: Article

References (12)

1. Spector R, Park GD, Johnson GF, Vesell ES. Therapeutic drug monitoring. Clin Pharmacol Ther 1988;43:345-53.
2. DiPiro JT, Blouin RA, Pruemer JM, Spruill WJ. Concepts in clinical pharmacokinetics: a self-instructional course. 2nd ed. Bethesda, MD: American Society of Health-System Pharmacists, Inc., 1996:9.
3. Mclnnes GT. The value of therapeutic drug monitoring to the practising physician - an hypothesis in need of testing. Br J Clin Pharmacol 1989; 27:281-4.
4. Westgard JO, Barry PL. Analytical processes: the production processes in clinical laboratories. In: Cost-effective quality control: managing the quality and productivity of analytical processes. Washington, DC: AACC Press, 1986:41-2.
5. Bermes EW Jr, Erviti V, Forman DT. Statistics, normal values and quality control. In: Tietz NW, ed. Fundamentals of clinical chemistry. Philadelphia: WB Saunders Co., 1976:64.
6. Whitehead TP. Types of variance in analytical results. In: Myhre BA, ed. Quality control in clinical chemistry. New York: Wiley and Sons, 1977:12.
7. Brooks Z, Massarella G, Plaut D. How total error can save time and money for the lab. Medical Lab Observer 1994;26:48-54.
8. Chandler MHH. Clinical pharmacokinetics service policy and procedure manual. 19th ed. Lexington, KY: University of Kentucky Medical Center, 1996.
9. Jusko WJ, Thomson AW, Fung J, McMaster P, Wong SH, Zylber-Katz E, et al. Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit 1995;17:606-14.
10. Product information. Tacrolimus IMx assay. Abbott Park, IL: Abbott Laboratories, 1995.
11. Product information. Tacrolimus IMx assay. Abbott Park, IL: Abbott Laboratories, 1996.
12. Schumacher GE, Barr JT. Making serum drug levels more meaningful. Ther Drug Monit 1989;11:580-4.